The journal of prevention of Alzheimer's disease
Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence.
Lin Qi, Fangxue Zheng, Mengjiao Tu, Reema Abdullah, Yilei Zhao, Xinhui Su, Dan Zhou, Guoping Peng
Published: 202610.1016/j.tjpad.2025.100473
Abstract
BACKGROUND: Safety profiles of lecanemab, an anti-amyloid-β antibody for the treatment of early Alzheimer's disease (AD), remain uncertain and may vary between randomized controlled trials (RCTs) and real-world evidence (RWE) studies. OBJECTIVES: Thi…
Preview only. Read the full abstract at the source